ID 404875471 · FY 2018–2024 · 7 years
კომპანიის ძირითადი საქმიანობაა ესთეტიკური და სამედიცინო მომსახურების გაწევა და მათთან დაკავშირებული პროდუქციის რეალიზაცია.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 54.5% | 51.6% | 55.5% | 53.4% | 56.0% | 63.7% | 60.3% |
| EBITDA Margin | 38.1% | 38.0% | 35.1% | 31.9% | 31.2% | 32.7% | 26.4% |
| EBITDAR | 888 | 1,064 | 809 | 979 | 1,100 | 1,307 | 1,311 |
| EBITDAR Margin | 39.5% | 39.2% | 36.5% | 32.9% | 32.1% | 33.4% | 27.1% |
| EBIT Margin | 34.8% | 35.0% | 31.1% | 28.0% | 26.1% | 28.6% | 23.1% |
| Net Profit Margin | 32.9% | 33.6% | 17.5% | 29.4% | 28.3% | 26.0% | 19.9% |
| Operating Expense % of Sales | 16.3% | 13.5% | 20.4% | 21.5% | 24.8% | 31.0% | 33.9% |
| Returns | |||||||
| Return on Assets (ROA) | 41.1% | 49.3% | 23.4% | 55.6% | 47.9% | 39.5% | 33.2% |
| Return on Equity (ROE) | 60.2% | 576.3% | 88.0% | 73.9% | 52.8% | 43.0% | 34.7% |
| ROIC [EBIT / Invested Capital] | 58.3% | 115.7% | 78.9% | 57.9% | 50.0% | 53.0% | 48.4% |
| Leverage & liquidity | |||||||
| Debt-to-Assets | 31.7% | 41.4% | 31.8% | 22.6% | 7.4% | 5.2% | 1.6% |
| Debt-to-Equity | 0.46x | 4.84x | 1.20x | 0.30x | 0.08x | 0.06x | 0.02x |
| Debt-to-EBITDA | 0.66x | 0.74x | 0.68x | 0.37x | 0.14x | 0.10x | 0.04x |
| Equity-to-Assets | 68.3% | 8.6% | 26.6% | 75.3% | 90.8% | 92.0% | 95.9% |
| Net Debt | 114 | 664 | 435 | 253 | -46 | -257 | -464 |
| Cash & Equivalents | 457 | 102 | 93 | 102 | 196 | 390 | 510 |
| Total Debt | 571 | 766 | 528 | 355 | 150 | 133 | 46 |
| Efficiency & working capital | |||||||
| Inventory Turnover | N/A | 2.53x | 2.15x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | 144.2 | 169.6 | N/A | N/A | N/A | N/A |
| Receivables Turnover | 15.00x | 33.99x | 118.98x | 62.96x | 26.34x | 18.12x | 14.06x |
| Days Sales Outstanding (DSO) | 24.3 | 10.7 | 3.1 | 5.8 | 13.9 | 20.1 | 26.0 |
| Payables Turnover | N/A | 129.72x | 77.39x | 247.10x | 401.94x | 169.45x | 171.31x |
| Days Payable Outstanding (DPO) | N/A | 2.8 | 4.7 | 1.5 | 0.9 | 2.2 | 2.1 |
| Cash Conversion Cycle | 24.3 days | 152.1 days | 167.9 days | 4.3 days | 12.9 days | 18.0 days | 23.8 days |
| Asset Turnover | 1.25x | 1.47x | 1.34x | 1.89x | 1.69x | 1.52x | 1.67x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | 51 | -135 | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | 51 | -135 | N/A | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | 5.9% | -13.1% | N/A | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.